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Protein kinase D regulates positive selection
of CD4þ thymocytes through phosphorylation
of SHP-1
Eri Ishikawa1, Hidetaka Kosako2, Tomoharu Yasuda3,w, Masaki Ohmuraya4,w, Kimi Araki4, Tomohiro Kurosaki3,5,
Takashi Saito6,7 & Sho Yamasaki1
Thymic selection shapes an appropriate T cell antigen receptor (TCR) repertoire during T cell
development. Here, we show that a serine/threonine kinase, protein kinase D (PKD),
is crucial for thymocyte positive selection. In T cell-speciﬁc PKD-deﬁcient (PKD2/PKD3
double-deﬁcient) mice, the generation of CD4 single positive thymocytes is abrogated. This
defect is likely caused by attenuated TCR signalling during positive selection and incomplete
CD4 lineage speciﬁcation in PKD-deﬁcient thymocytes; however, TCR-proximal tyrosine
phosphorylation is not affected. PKD is activated in CD4þCD8þ double positive (DP)
thymocytes on stimulation with positively selecting peptides. By phosphoproteomic analysis,
we identify SH2-containing protein tyrosine phosphatase-1 (SHP-1) as a direct substrate of
PKD. Substitution of wild-type SHP-1 by phosphorylation-defective mutant (SHP-1S557A)
impairs generation of CD4þ thymocytes. These results suggest that the PKD–SHP-1 axis
positively regulates TCR signalling to promote CD4þ T cell development.
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A
n appropriate ab T cell receptor (TCR) repertoire is
shaped in the thymus through multiple selection steps. In
this process, transduction of signals through the TCR
in CD4þCD8þ double positive (DP) thymocytes determines
CD4/CD8 lineage speciﬁcation and generates CD4þCD8 and
CD4CD8þ single positive (SP) thymocytes. At the DP stage,
interaction of the TCR with self-peptides on major histocompat-
ibility complex (MHC) molecules generates positive-selecting
signals. DP thymocytes that undergo positive selection increase
their surface expression of CD5, CD69 and TCR and differentiate
into a CD4þCD8int transitional stage. At this stage, persistent
TCR signalling promotes CD4 lineage speciﬁcation through a
series of transcriptional programs1. However, the molecular
mechanisms by which the signal duration is translated into
speciﬁc responses have yet to be fully deﬁned.
It is well established that sequential tyrosine phosphorylation
events triggered by protein tyrosine kinases (PTKs), such as Src-,
Syk- and Tec-family PTKs, orchestrate TCR signalling during
T cell development2. Serine/threonine kinases also regulate T cell
development by controlling transcriptional and metabolic
programs3. Until now, loss of several serine/threonine kinases
has been reported to result in defective T cell development4–10.
However, the crosstalk between serine/threonine kinase and
tyrosine phosphorylation cascade is not clearly understood.
PKD, initially called PKCm, is a serine/threonine kinase family
now classiﬁed within the CaMK group and separated from the
AGC group (named for PKA, PKG and PKC)11. The three
isoforms, PKD1, PKD2 and PKD3, are encoded by different
genes, prkd1, prkd2 and prkd3, respectively. All PKD isoforms
have a highly conserved amino acid sequence with a
diacylglycerol (DAG)-binding domain, pleckstrin homology
(PH) domain and kinase domain11. Among them, PKD2 is
abundantly expressed in T cells12,13 and is phosphorylated on
TCR stimulation14. In addition, constitutively active PKD2 drives
T cell development15. However, thymic selection was not grossly
disturbed in PKD2-deﬁcient mice13. Until now, no studies have
addressed the role of PKD in thymocyte development using mice
lacking all PKD isoforms, and the downstream substrates of PKD
in thymocytes have not fully been elucidated.
Inhibitory signalling molecules, such as protein tyrosine
phosphatases (PTPs), modulate TCR signalling and thus
contribute to setting the threshold for thymocyte selection16,17.
In particular, SH2-containing protein tyrosine phosphatase-1
(SHP-1) is reported to regulate thymic selection through a
variety of proposed mechanisms18–21. The inhibitory activity of
SHP-1 is regulated by binding to the phosphorylated targets via
SH2 domains and by phosphorylation of its C-terminal tyrosines
(Try536 and Tyr564)17,22. However, the role of serine/threonine
phosphorylation in the function of SHP-1 remains unclear23.
In this study, we established mice lacking all PKD isoforms in
T cells. The generation of CD4 SP thymocytes is impaired in these
T cell-speciﬁc PKD-deﬁcient mice. Using a phosphoproteomic
approach, we identify SHP-1 as a direct substrate for PKD. The
phosphorylation of SHP-1 by PKD positively regulates TCR
signalling. Collectively, we demonstrate that the PKD–SHP-1 axis
is required for CD4þ T cell development.
Results
PKD is phosphorylated in preselection DP thymocytes. We ﬁrst
investigated whether PKD is activated on TCR engagement in
thymocytes by evaluating phosphorylation of its activation loop.
To address this, ‘unengaged’ DP thymocytes that have never
encountered self-peptides were prepared. To obtain preselection
thymocytes bearing antigen-speciﬁc TCR, bone marrow (BM)
cells from OT-I TCR Tg mice were transferred into transporter
associated with antigen processing (TAP)-deﬁcient mice, which
lack functional MHC class I. The preselection thymocytes were
stimulated with OVA peptides that differ in afﬁnity such as
OVA257–264 (SIINFEKL) (strong agonist), T4 (intermediate
agonist) and G4 (weak agonist). To evaluate PKD activation,
we established anti-phospho-PKD1/2/3 Abs that recognize
phosphorylated activation loops containing a common sequence
shared by all PKDs (Fig. 1a). Substantial PKD activation, as
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Figure 1 | Expression of PKD isoforms in the thymus. (a) Characterization
of anti-phospho-PKD1/2/3 Abs (anti-pPKDs). Reactivities of anti-pPKDs
were evaluated by western blot analysis of lysates from HEK293 cells
overexpressing WT PKD2 and mutants. Note that overexpressed PKD2 is
constitutively phosphorylated. Anti-PKD1/2/3 (anti-PKDs) blotting was
also performed as a control. (b) Preselection OT-I DP thymocytes, that are
obtained from TAP-deﬁcient mice transferred with OT-I Tg BM cells, were
stimulated with a variety of OVA peptides (10 mM) for the indicated times
and phosphorylation of PKD and Erk was analysed. PKD, Erk and b-actin
were used as loading controls. (c) RT-PCR analysis of expression of PKD
isoforms in the thymus, spleen, ovary and lung from C57BL/6 mice. mRNA
expression of b-actin was analysed as a control. Threefold serial dilutions of
cDNAs were used as templates. (d) RT-PCR analysis of PKD isoforms
expressions in various cell subsets sorted by ﬂow cytometry from WT
thymocytes. Results are presented as expression relative to b-actin. ND, not
detected. (e) mRNA copy number was evaluated by molecular indexing
assay. The amount of RNA used in the experiment is indicated on the x axis.
Data are representative of two independent experiments (a–c). Data are
presented as mean±s.d. of triplicate assays and representative of two
independent experiments (d,e).
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assessed by anti-phospho-PKDs Abs, was induced by low-afﬁnity
peptides (Fig. 1b), implying a role for PKD in positive selection.
We next examined the PKD isoforms expressed in thymocytes.
Reverse transcription-PCR (RT-PCR) analyses conﬁrmed that
thymocytes express abundant PKD2, less PKD3 and undetectable
PKD1 mRNA (Fig. 1c,d), as previously reported13. The lack of
PKD1 expression in thymocytes was further veriﬁed by evaluating
mRNA copy number using a molecular indexing assay (Fig. 1e)24.
To generate T cells lacking all PKD isoforms, we established T
cell-speciﬁc PKD2/PKD3 double-deﬁcient mice using Lck-Cre Tg
mice (PKD2/3DT) (Fig. 2a,b). We conﬁrmed that none of the
three PKD isoforms was expressed in PKD2/3DT thymocytes
using Abs reacting with PKD1, PKD2 and PKD3 (Fig. 2c,d).
Defective T cell development in PKD2/3DT mice. In PKD2/3DT
mice, the proportion and number of CD4 SP thymocytes were
markedly lower compared with wild-type (WT) mice, whereas
those from single-deﬁcient (PKD2DT or PKD3DT) mice were not
altered (Fig. 3a,b). These trends were more prominent in the
TCRhi-gated mature CD4 SP population (Fig. 3a, lower panels).
Consistent with the reduction of CD4 SP cells, PKD2/3DT mice
had small and fragmented thymic medulla (Fig. 3c). The above
results might be due to a possible survival defect of CD4 SP cells
(Fig. 3d; Supplementary Fig. 1), as Bcl-2 expression was reduced
by half in PKD2/3DT cells (Fig. 3e). However, this possibility
seems unlikely as promotion of survival by a Bcl-2 transgene in
PKD2/3DT mice (Fig. 3f) failed to restore the proportion and
number of CD4 SP thymocytes (Fig. 3g,h). Thus, PKD is likely to
regulate CD4 SP cell generation beyond any effects on survival.
A small number of CD4 SP thymocytes in PKD2/3DT mice
expressed lower levels of TCR and CD5 on the cell surface
(Fig. 3i). This phenomenon was also observed in CD8 SP cells,
suggesting that TCR signalling is impaired during positive
selection in PKD2/3DT mice.
Role of PKD in positive and negative selection. To examine the
role of PKD in positive selection, we crossed PKD2/3DT mice with
MHC class II-restricted OT-II TCR transgenic (Tg) mice. In
OT-II PKD2/3DT mice, the percentage of CD4 SP thymocytes
was reduced to one-tenth that of PKD-sufﬁcient OT-II mice
(Fig. 4a), demonstrating that PKD is critically involved in positive
selection for the CD4 lineage. In the MHC class I-restricted OT-I
TCR background, the proportion of mature CD8 SP thymocytes
in PKD2/3DT mice was reduced compared with that in control
OT-I Tg mice (Fig. 4b), albeit less severe than in OT-II
background. Furthermore, the expression of Tg-TCR was lower
in PKD2/3DT mice (Fig. 4a,b, lower panels). Analysis of
female H–Y TCR Tg mice supported this ﬁnding, as CD8 SP
development was impaired in H–Y PKD2/3DT mice (Fig. 4c).
Thus, positive selection for both the CD4 and CD8 lineages is
impaired in PKD2/3DT mice, particularly when the abTCR is
ﬁxed by transgenes.
We next investigated the function of PKD in negative selection
using two different models. In male H–Y Tg PKD2/3DT mice, the
percentage and number of DP thymocytes were signiﬁcantly higher
than in control male H–Y Tg mice, suggesting inefﬁcient negative
selection in PKD-deﬁcient thymocytes (Fig. 4d). Strikingly, male
H–Y TgPKD2/3DT mice had CD8 SP thymocytes bearing high
levels of the H–Y TCR (Fig. 4e). Furthermore, the peripheral T cells
in male H–Y TgPKD2/3DT mice expressed normal levels of
CD8, unlike low-level expression in WT H–Y controls (Fig. 4f).
These results suggest that the loss of PKD results in a shift of the
normal positive selection window towards high self-reactivity due
to impaired TCR signalling in thymocytes.
For the second model, we used a clonal deletion model
triggered by endogenous superantigens. Thymocytes bearing
Vb5þ and Vb11þ TCR are deleted in the presence of mtv-8
and mtv-9 on I–E (Fig. 4g, H-2b/d)25. This deletion persisted in
PKD single-deﬁcient mice; however, it was signiﬁcantly blocked
in PKD2/3DT (H-2b/d) mice (Fig. 4g, left panels). Irrelevant
Vb6þ cells were not affected by the absence of PKD (Fig. 4g,
right panel). Thus, these two models reveal that PKD is involved
in negative selection.
Collectively, our results indicate that PKD is critical for positive
selection to the CD4 lineage and is also required for optimal
positive selection to the CD8 lineage and negative selection.
Impaired CD4þCD8int thymocyte generation by loss of PKD.
DP thymocytes stimulated with positive-selecting peptides
express CD69 and then differentiate into CD4þCD8int inter-
mediate cells, which are the precursors to both CD4 and CD8 SP
thymocytes1. Although the number of CD69þ DP cells was not
altered in PKD2/3DT mice, the CD4þCD8int subpopulation was
signiﬁcantly decreased (Fig. 5a). The impaired generation of the
CD4þCD8int population was also evident in OT-I and OT-II
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Figure 2 | Generation of PKD-deﬁcient mice. (a,b) Genomic structures
and targeting constructs of PKD2 (a) and PKD3 (b). Exons encoding the
DxxxN motif and the phosphorylation sites required for kinase activity are
ﬂanked by loxP sites (indicated by open triangles). (c) Total thymocytes
from WT, PKD2ﬂ/ﬂ Lck-Cre Tg (PKD2DT), PKD3ﬂ/ﬂ Lck-Cre Tg
(PKD3DT) and PKD2ﬂ/ﬂ PKD3ﬂ/ﬂ Lck-Cre Tg (PKD2/3DT) mice were
analysed for PKD expression by western blotting using anti-PKDs antibody.
b-actin was used as a loading control. (d) PKD phosphorylation in
thymocytes on TCR stimulation by CD3 cross-linking for 2min was
detected using anti-pPKDs. Data are representative of two independent
experiments (c,d).
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TCR Tg backgrounds (Fig. 5b), indicating that PKD is required
for the transition from the DP to the CD4þCD8int
stage. Consistent with this, the CD4þCD8int population in
PKD2/3DT mice showed lower expression levels of CD5 than in
WT mice, suggesting that loss of PKD led to the attenuation of
TCR signalling during differentiation of DP to CD4þCD8int
stage (Fig. 5c).
To conﬁrm this assumption, we conducted two-step differ-
entiation assay in vitro. During recovery culture after cross-
linking of TCR and co-receptor, DP thymocytes differentiate into
CD4þCD8int cells (Fig. 5d), as previously reported26. However,
PKD2/3DT DP thymocytes generated a much lower percentage of
CD4þCD8int cells than WT thymocytes after this treatment
(Fig. 5d). Collectively, these results suggest that PKD regulates the
TCR signals required for transition of DP to CD4þCD8int
thymocytes during positive selection.
PKD mediates signals triggered by weak-afﬁnity peptides. To
evaluate the strength of TCR signals, we performed quantitative
assays using OVA peptide variants to stimulate thymocytes from
TCR Tg mice. Ag peptide-induced co-receptor downregulation is
a molecular indicator of the strength of TCR signalling in DP
thymocytes27. Indeed, stimulation of thymocytes from OT-II
TCR Tg mice resulted in co-receptor downregulation in
accordance with the peptide afﬁnity as seen using OVA323–339
(strong agonist), R9 (weak agonist) and F9 (very weak agonist)
(Fig. 5e, open circles)28. However, the responses were suppressed
in PKD-deﬁcient OT-II thymocytes, even on stimulation with the
R9 variant (Fig. 5e, closed circles). Likewise, upregulation of
CD69 and CD5 was also reduced in the absence of PKD (Fig. 5f).
To further investigate, we stimulated thymocytes bearing OT-I
TCR. Again, the co-receptor downregulation faithfully reﬂected
the peptide afﬁnity: namely, OVA257–264 is the most potent,
followed by T4 and G4 (Fig. 5g, open circles). We found that in
the absence of PKD, the response was signiﬁcantly attenuated
when stimulated with a low-afﬁnity variant, G4, which is known
as a positive-selecting ligand (Fig. 5g, closed circles)29. These
ﬁndings suggest that PKD is required for TCR signalling triggered
by weak-afﬁnity ligands, which is consistent with the above
observation that positive selection is severely affected in
PKD2/3DT mice.
PKD is involved in CD4 lineage speciﬁcation. As the generation
of CD4 SP cells was more severely affected than CD8 SP cells in
PKD2/3DT mice (Fig. 3a,b), we next investigated whether PKD
inﬂuences CD4 lineage commitment. If PKD2/3DT thymocytes
have an intrinsic defect in commitment to the CD4 lineage, they
b
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Figure 3 | Defective T cell development in the absence of PKD. (a) Total
thymocytes (upper panels) and TCRbhi thymocytes (lower panels) from
WT, PKD2ﬂ/ﬂ Lck-Cre Tg (PKD2DT), PKD3ﬂ/ﬂ Lck-Cre Tg (PKD3DT) and
PKD2ﬂ/ﬂ PKD3ﬂ/ﬂ Lck-Cre Tg (PKD2/3DT) mice were analysed for CD4
and CD8 expression by ﬂow cytometry. Numbers in quadrants indicate
percentages. (b) Absolute cell numbers of total thymocytes, CD4 SP and
CD8 SP subsets. Each symbol represents an individual mouse. **Po0.01,
NS, not signiﬁcant. (c) Hematoxylin and eosin staining of thymus sections.
M, medulla; C, cortex. Scale bar, 1mm. (d) In vitro survival of thymocytes.
Total thymocytes from WT, PKD2DT, PKD3DT and PKD2/3DT mice were
cultured in vitro and the live cell number of CD4 SP cells was analysed by
staining with Annexin V and propidium iodide followed by ﬂow cytometry
analysis after the indicated numbers of days. **Po0.01. (e) Real time PCR
analysis of Bcl-2 mRNA expression in CD4þCD8int thymocytes. Result is
presented as expression relative to b-actin. **Po0.01. (f) Analysis of
PKD2/3DT Bcl-2 Tg mice. In vitro survival of thymocytes from WT,
PKD2/3DT and PKD2/3DT Bcl-2 Tg mice were analysed as in (d).
**Po0.01. (g) Flow cytometry analysis of CD4 and CD8 expression on
TCRbþ thymocytes from WT, PKD2/3DT and PKD2/3DTBcl-2 Tg mice.
(h) Average cell number of CD4þCD8int and CD4 SP thymocytes and the
ratio of CD4 SP to CD8 SP thymocytes. *Po0.05, **Po0.01. (i) TCRb and
CD5 expression on DP and CD4 and CD8 SP thymocytes from WT (ﬁlled
histograms) and PKD2/3DTmice (open histograms). Data are presented as
mean±s.d. of triplicate assays (d–f) and eight mice (h) and are
representative of ﬁve (a,i), three (c,f,g), four (d) and two (e) independent
experiments. Unpaired two-tailed Student’s t test is used to calculate
P values.
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should give rise to CD8 SP cells even in the absence of MHC class
I (in an MHC class II-dependent manner), which is called
‘CD8-redirection’ (refs 30,31). To address this possibility,
we transferred BM cells from WT or PKD2/3DT mice to
TAP-deﬁcient mice. PKD-deﬁcient BM cells, but not WT
BM cells, gave rise to mature CD8 SP thymocytes even
in TAP-deﬁcient hosts lacking functional MHC class I (Fig. 6a),
suggesting that PKD2/3DT cells are defective in lineage
commitment to CD4 SP thymocytes.
In fact, expression of ThPOK, a critical regulator of
CD4 lineage commitment32, was decreased in PKD2/3DT
CD4þCD8int cells, whereas Runx3, a transcription factor
essential for CD8 lineage speciﬁcation, was not decreased
(Fig. 6b). Forced expression of ThPOK restored the percentage
of CD4 SP thymocytes to nearly WT levels (Fig. 6c). However, the
expression of the CD5 maturation marker in CD4þCD8int cells
remained low even in the presence of ThPOK transgene (Fig. 6d).
Thus, these results suggest that PKD regulates the development of
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Figure 4 | Impaired positive and negative selection in the absence of PKD. (a,b) Thymocytes from WT and PKD2/3DTmice crossed with OT-II TCR Tg
(a) or OT-I TCR Tg (b) were analysed for expression of CD4 and CD8 by ﬂow cytometry. Numbers indicate the percentages of cells in each gate (upper
panels). The percentage of Va2þ cells is shown (lower panels). (c) Analysis of CD4 and CD8 expression (upper panels) and T3.70 expression (lower
panels) of thymocytes from female (f) H–Y TCR Tg mice. (d) Analysis of male (m) H–Y TCR Tg mice (left panels). The average number of DP thymocytes is
shown (bar graph). **Po0.01. (e) T3.70þ thymocytes from male H–Y TCR Tg mice were analysed for CD8 SP population. (f) T3.70þ splenocytes from
male H–Y Tg and H–Y Tg PKD2/3DT mice were analysed for CD8 expression. Mean ﬂuorescent intensities (MFIs) of gated population are 208.41 and
337.32, respectively. (g) Negative selection induced by endogenous superantigens. Percentage of Vb5þ , Vb11þ and Vb6þ cells among CD4 SP
thymocytes from B6 (H-2b) WT, PKD2DT, PKD3DT and PKD2/3DTmice, backcrossed (H-2b/d) or not (H-2b/b) onto B10.D2 (H-2d) mice was analysed by
ﬂow cytometry. Each circle represents an individual mouse. Small horizontal lines indicate the mean. *Po0.05, **Po0.01. Data are presented as
mean±s.d. of eight mice (d, bar graph) and are representative of four independent experiments (a–f). Unpaired two-tailed Student’s t test is used to
calculate P values.
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CD4 SP cells through at least two mechanisms: (i) promotion of
TCR signals in the DP stage that trigger transition to the
CD4þCD8int stage; and (ii) speciﬁcation of CD4 lineage
development via a ThPOK-dependent process.
SHP-1 is a PKD substrate in thymocytes. The above results
demonstrate that PKD promotes TCR signalling during thymic
selection. However, proximal signalling events including Ca2þ
inﬂux and Erk activation following TCR ligation were comparable
between WT and PKD2/3DT thymocytes (Fig. 7a,b). Furthermore,
in DP cells, TCR-induced tyrosine phosphorylation of proximal
signalling molecules, such as CD3z and ZAP-70, as well as
MAPKs, such as Erk, p38 and JNK, was unaffected by the loss of
PKD (Fig. 7c).
On the other hand, expression of a truncated PKD2 transgene
lacking the kinase domain inhibited the generation of CD4 SP
thymocytes (Fig. 7d), suggesting that the PKD kinase activity is
required for thymocyte development.
Hence, to clarify downstream signalling events, we performed
an unbiased proteomic search for novel PKD substrates in
thymocytes. To identify proteins that exhibit TCR-induced
phosphorylation in WT but not PKD-deﬁcient thymocytes,
phosphoproteins from unstimulated WT, stimulated WT and
stimulated PKD2/3DT thymocytes were labelled with Cy2 (blue),
Cy3 (red) and Cy5 (green) ﬂuorescent markers, respectively,
and analysed by two-dimensional ﬂuorescence difference gel
electrophoresis (2D-DIGE)33. We detected six ‘red’ spots
representing proteins that were phosphorylated in a
stimulation- and PKD-dependent manner (Fig. 8a). These spots
were identiﬁed to be pro-IL-16, SHP-1, NCK1 and Gads by mass
spectrometry (MS) (Fig. 8a,b; Supplementary Data 1). SHP-1,
NCK1 and Gads are reported to be involved in T cell
development17,34,35. Phosphate-afﬁnity SDS–PAGE (Phos-tag)
western blotting33 showed that the migration of SHP-1, NCK1
and Gads was retarded (indicating phosphorylation) in
stimulated-WT thymocytes (Fig. 8c; Supplementary Fig. 2). In
PKD2/3DT cells, the levels of phosphorylation of these proteins
were reduced (Fig. 8c). In vitro kinase assays with recombinant
PKD2 and PKD3 revealed that SHP-1, Gads and NCK1 are direct
substrates for PKD2/3, and were phosphorylated at an efﬁciency
similar to substrates previously identiﬁed in other tissues
(Fig. 8d)36. We next used MS and site-directed mutagenesis,
and identiﬁed the sites phosphorylated by PKD as SHP-1 Ser557,
Gads Ser186 and NCK1 Ser85 (Fig. 8e, Supplementary Fig. 3 and
Supplementary Data 2). Notably, these sites are similar in
sequence to the PKD consensus phosphorylation motif,
L/V/IxRxxpS/T (Fig. 8f)37.
These substrates were also phosphorylated in OT-I thymocytes
on stimulation with various OVA peptides as assessed by
Phos-tag western blotting. Among these substrates, the phos-
phorylation of SHP-1 was largely dependent on PKD2/3 (Fig. 9a).
In order to further examine SHP-1 phosphorylation in vivo,
tryptic phosphopeptides were enriched using TiO2 from each
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Figure 5 | Role of PKD in early differentiation of DP thymocytes.
(a) Average cell number of CD69þDP and CD4þCD8int thymocytes from
WT and PKD2/3DT mice was analysed by ﬂow cytometry. *Po0.05.
(b) Average cell number of CD4þCD8int thymocytes from OT-I or OT-II Tg
mice. **Po0.01. (c) CD5 expression on TCRbhiCD4þCD8int thymocytes
from WT and PKD2/3DT mice. (d) Average percentage of CD4þCD8int
cells from recovery culture in two-step differentiation assay. **Po0.01.
(e) Co-receptor downregulation (dulling) on OT-II DP thymocytes on
stimulation with OVA peptide variants (OVA323–339, R9 and F9) was
analysed by ﬂow cytometry. The data are presented as the per cent
downregulation, which is the percentage of DP thymocytes with reduced
levels of CD4 and CD8 relative to the percentage of DP thymocytes
observed in unstimulated condition. *Po0.01. (f) Percentage of CD69þ
cells (upper panels, *Po0.0001) and CD5þ cells (lower panels,
*Po0.00001) in DP thymocytes on OVA peptides stimulation.
(g) Co-receptor downregulation (dulling) on preselection OT-I DP
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G4). The data are presented as in e. *Po0.01. Data are presented as
mean±s.d. of seven mice (a), ﬁve mice (b) and triplicate assays
(d) and are representative of ﬁve (c), three (d) or two (e–g) independent
experiments. Unpaired two-tailed Student’s t test is used to calculate
P values.
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thymocyte. The liquid chromatography (LC)–MS data revealed
that a phosphorylated peptide corresponding to amino
acid residues 555–570 was increased by TCR stimulation in a
PKD2/3-dependent manner (Fig. 9b, Supplementary Fig. 4 and
Supplementary Data 3). Tandem mass spectrometry (MS/MS)
analysis conﬁrmed phosphorylation at Ser557 of endogenous
SHP-1 derived from stimulated-WT thymocytes (Fig. 9c). Finally,
we developed an antibody that recognizes the phosphorylated
Ser557 in SHP-1. TCR stimulation increased the levels of
phospho-Ser557 SHP-1 in thymocytes from WT but not
PKD2/3DT mice (Fig. 9d). These results indicate that PKD
mediates TCR-induced phosphorylation of Ser557 in SHP-1.
Importantly, the Ser557 amino acid is highly conserved across
mammalian species (Fig. 9e).
Mutant SHP-1 (SHP-1S557A) suppresses thymocyte development.
To further examine the role of the SHP-1 phosphorylation in T
cell development, we turned to the DPK cell line, a pigeon
cytochrome c (PCC)-speciﬁc DP cell line that retains the potential
to undergo differentiation in vitro38. Stimulation of DPK cells
with cognate peptide on I–Ek resulted in downregulation of
CD8 expression and differentiation into CD4 SP cells as
previously reported38 (Fig. 10a, Mock). Forced expression of a
phosphorylation-defective mutant of SHP-1 (SHP-1S557A)
reduced the generation of CD4 SP cells (Fig. 10a). Likewise,
SHP-1S557A also inhibited CD5 upregulation induced by peptide
stimulation (Fig. 10b). These results suggest that SHP-1S557A can
suppress TCR signalling in a dominant negative manner and
that phosphorylation of Ser557 in SHP-1 promotes TCR signalling.
We ﬁnally examined the in vivo relevance of the phospho-
rylation of Ser557 in SHP-1 by establishing knock-in mice
expressing mutant SHP-1 (SHP-1S557A/S557A mice) (Fig. 10c).
Thymocytes from SHP-1S557A/S557A mice expressed comparable
amount of SHP-1 to that of WT, whereas TCR-induced
phosphorylation was impaired (Fig. 10d), indicating that Ser557
is a major phosphorylation site on TCR stimulation. To address
the role of this site, we evaluated the ability of SHP-1S557A/S557A
thymocytes to develop into SP cells in the context of competition
with WT. CD3e-deﬁcient (CD3eD5/D5) mice lacking T cells were
transferred with mixed BM cells from CD45.1þ WT and
CD45.2þ SHP-1S557A/S557A mice and analysed after T cell
reconstitution. SHP-1S557A/S557A thymocytes showed impaired
development into CD4 SP population compared with WT
thymocytes (Fig. 10e), indicating that Ser557 is required for the
optimal generation of CD4 SP thymocytes. Collectively, these
results suggest that the phosphorylation of Ser557 in SHP-1 can
positively regulate TCR signalling in DP thymocytes to promote
T cell development.
Discussion
In this study, we established T cell-speciﬁc PKD-deﬁcient mice to
characterize the role of PKD in T cell development. PKD appears
to control the generation of CD4 SP thymocytes through
promoting (i) TCR signalling during positive selection, and
(ii) CD4 lineage speciﬁcation. Since the decreased number of
CD4þCD8int cells in PKD2/3DT mice was restored by a Bcl-2
transgene (Fig. 3h), an important function of PKD during positive
selection may be promoting survival that allows DP cells to
differentiate into the CD4þCD8int stage. On the other hand,
defective CD4 lineage speciﬁcation on loss of PKD is likely due to
the incomplete induction of ThPOK during positive selection,
as CD4/CD8 ratio was restored by ThPOK transgene, but not by
Bcl-2. Optimal ThPOK induction requires ‘duration’ of TCR
signalling during positive selection39. In contrast, the expression
of Runx3, a transcription factor essential for CD8 lineage
speciﬁcation, is controlled by TCR-induced immediate
upregulation of IL-7R and subsequent IL-7 signalling40. As
Runx3 induction occurred normally in PKD-deﬁcient mice
(Fig. 6b), PKD is apparently dispensable for the transient TCR
signalling required for Runx3 induction. In this respect, we
speculate that another critical role of PKD may be to maintain the
‘duration’ of TCR/co-receptor signalling after sensing a weak-
afﬁnity ligand. Consistent with this idea, PKD was efﬁciently
activated by stimulation with weak-afﬁnity peptide variants in
preselection DP thymocytes (Supplementary Fig. 5).
PKD2 is abundantly expressed in thymocytes, while the
amount of PKD3 is considerably lower. Nevertheless, the
strikingly different phenotype of PKD2/3DT versus PKD2DT mice
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demonstrates that a limited amount of PKD3 is sufﬁcient to
support SP thymocyte generation. The redundant functions of
PKD2 and PKD3 in T cell development suggest that their
substrate speciﬁcities are likely to overlap. Indeed, all substrates
tested in this study were phosphorylated by both PKD2 and
PKD3 with similar efﬁciencies (Fig. 8d). The PKD consensus
phosphorylation motif has been reported to be L/V/IxRxxS/T37.
The new phosphorylation sites that we have identiﬁed
herein are similar but not identical to this motif (Fig. 8f).
This ﬁnding underscores the important contribution of
unbiased phospho-proteomics33,41, in addition to motif-based
approaches42, in identifying novel kinase substrates.
It has been suggested that SHP-1 dephosphorylates several key
molecules involved in TCR signalling mainly through interactions
with ITIM-containing transmembrane proteins17. Recently,
Themis, a molecule critical for positive selection, was reported
to recruit SHP-1 to antagonize TCR signalling, thereby
preventing the apoptosis of DP cells that encountered weak
agonists during positive selection43, although some debate
exists44. Given that loss of Themis or PKD cause similar defects
in T cell development, one might speculate that PKD also
antagonizes TCR signalling to ensure positive selection. However,
this possibility seems less likely, as the expression levels of CD5,
CD69 (Fig. 5f) and Nur77 (Supplementary Fig. 6), which
represent the summation of TCR signalling intensity45,46, were
reduced in PKD-deﬁcient cells. This ﬁnding is consistent with
the fact that active PKD induces upregulation of CD5 in
thymocytes15. In addition, a ‘selection shift’ from negative
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selection to positive selection has been reported in mice with
defective TCR signalling, such as ZAP-70-mutated mice
or CD3z / mice47,48, similar to what we observe herein
for PKD2/3DT mice (Fig. 4e,f). In contrast, in Themis / mice,
proximal TCR signalling is enhanced rather than attenuated43.
Therefore, although PKD and Themis can both act on SHP-1,
they appear to regulate TCR signalling in opposite directions. The
generation of Themis /  PKD2/3DT triple-deﬁcient mice will
clarify this issue.
What is the molecular basis for the positive signalling resulting
from the phosphorylation of Ser557 in SHP-1? There are at least
three possibilities: First, the phosphorylation by PKD may
constrain the inhibitory function, such as phosphatase activity,
of SHP-1. Alternatively, the phosphorylation might alter the
proper cellular localization of SHP-1 away from the area where
efﬁcient inhibition of TCR signalling takes place. Indeed, a 6-mer
motif including Ser557 in SHP-1 is reported to regulate its
subcellular localization49. Second, we cannot rule out the
possibility that serine-phosphorylated SHP-1 dephosphorylates
proteins containing tyrosines that on phosphorylation, negatively
regulate TCR signalling. For example, SHP-1 dephosphorylates
the C-terminal regulatory tyrosine of Src family PTKs in
osteoblasts to activate their kinase activities50. Third, SHP-1
may function as an adaptor rather than a phosphatase through
its C-terminal phospho-Ser557, and may recruit positive
regulators into the vicinity of the TCR. In every case, it would
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be extremely intriguing to identify the protein(s) that selectively
bind to Ser557-phosphrylated SHP-1. Johnson et al.51 recently
reported that T cell-speciﬁc SHP-1 deletion using Cd4-Cre Tg
mice had no obvious effect on T cell development. This may be
explained by the loss of both positive and negative regulation via
SHP-1 in thymocytes lacking SHP-1 protein.
The observation that the defects found in SHP-1S557A/S557A
mice are milder than that of PKD2/3DT mice could be explained
by a possible contribution of other PKD substrates, such as Gads
and NCK1. Indeed, co-transfection of phosphorylation-defective
forms of three other PKD substrates (Gads, NCK1 and pro-IL-16)
together with SHP-1S557A resulted in more severe impairment in
CD5 upregulation (Supplementary Fig. 7). Thus, we cannot
exclude the possibility that PKD might control T cell develop-
ment by modulating multiple TCR signalling pathways through
various substrates in addition to SHP-1.
Histone deacetylase 7 (HDAC7) is also reported to be a
substrate for PKD52 and we conﬁrmed this in in vitro kinase
assay (Fig. 8d), whereas we could not detect PKD-dependent
phosphorylation of HDAC7 in thymocytes by 2D-DIGE
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anti-SHP-1. Arrowheads indicate phosphorylated SHP-1 that showed stimulation-dependent mobility shift. (b) The extracted ion chromatogram of m/z
496.23096 corresponds to the quadruply charged SHP-1 phosphopeptide (TSpS557KHKEEVYENVHSK), which was increased by TCR stimulation in tryptic
phosphopeptides from WT thymocytes and was almost undetectable in those from stimulated PKD2/3DT thymocytes. The relative values of the peak area
are indicated. Note that the hextuply charged ion peak at a retention time of 21.70min was unrelated to this SHP-1 phosphopeptide. (c) Phosphorylation of
Ser557 was demonstrated by the MS/MS spectrum of the m/z 496.23 ion at a retention time of 7.52min in tryptic phosphopeptides from stimulated-WT
thymocytes. (d) Phosphorylation of Ser557 of SHP-1 was analysed by immunoblotting. Total thymocytes were stimulated by CD3 cross-linking for 2min and
analysed by anti-phospho-SHP-1 (Ser557) Abs. Total SHP-1 was blotted as a control. (e) Schematic structure of SHP-1 and sequence alignment of the
C-terminal region of SHP-1 that contains Ser residue corresponding to Ser557 of murine SHP-1 (shown in red). Data are representative of two independent
experiments (a–d).
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(Fig. 8a,b). HDAC7-deﬁcient mice show poor generation of SP
thymocytes53. However, the phenotype of PKD-deﬁcient mice is
unlikely to be attributed to HDAC7, as loss of HDAC7 results
in unique phenotypes, such as limited usage of TCR Ja segments,
which are not observed in PKD2/3DT mice. In addition, in
HDAC7-deﬁcient mice, the introduction of TCR transgenes
(OT-I or OT-II) reduced rather than exacerbated the defect in
thymocyte development53, which contrasts with the phenotypes
seen in PKD-deﬁcient mice.
Currently, the pathway upstream of PKD during thymic
selection is not clearly understood. PKD is activated by binding to
DAG and, more importantly, by phosphorylation of serine
residues in the activation loop (Ser707/711 in PKD2 and Ser731/735
in PKD3)3. In T cells, classical as well as novel PKCs, including
PKCa, d, e, Z and y, are implicated in the phosphorylation of
these residues14. Among them, PKCy and PKCZ are abundantly
expressed in DP thymocytes, and recently, PKCy /PKCZ /
double-deﬁcient mice were demonstrated to have a decreased
number of SP thymocytes compared with single-deﬁcient mice54.
In this regard, one can speculate that PKDy and PKCZ
act as upstream regulators of PKD after TCR engagement in
thymocytes. This hypothesis warrants further investigation.
In conclusion, we propose that the PKD represents one of the
molecular switches that converts weak TCR engagement to
positive selection and CD4 lineage speciﬁcation. The critical roles
of PTKs and PTPs in thymic selection have been clearly
established. The present study brings to light the additional
importance of serine/threonine kinases as key modulators of TCR
signalling cascade regulated by tyrosine phosphorylation during
thymic selection.
Methods
Mice. PKD2-ﬂoxed and PKD3-ﬂoxed mice were generated by homologous
recombination-mediated gene targeting in embryonic stem (ES) cells of C57BL/6
and 129 genetic background, respectively. PKD3-ﬂoxed mice were backcrossed to
C57BL/6 mice and ﬂoxed Neo cassette of each allele was deleted by crossing with
CAG-Cre Tg mice. Bcl-2 Tg mice55 were provided by J. Domen (The Children’s
Mercy Hospital, Kansas City, MO) by the courtesy of K. Ikuta (Kyoto University,
Kyoto, Japan). CD3eD5/D5 mice56 were provided by B. Malissen (Aix Marseille
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Figure 10 | Phosphorylation of SHP-1 Ser557 is critical for T cell development. (a,b) DPK cells expressing vector alone (Mock) or mutant SHP-1
(SHP-1S557A) were stimulated with the indicated concentrations of PCC peptides presented on DCEK cells expressing I–Ek. The percentages of CD4
SP thymocytes (a) and CD5þ cells in DP thymocytes (b) at day 3 were analysed by ﬂow cytometry. *Po0.05, **Po0.01. (c) Targeting construct
for establishment of SHP-1S557A knock-in mice. (d) Phosphorylation and expression level of SHP-1 in unstimulated- and TCR-stimulated-WT and
SHP-1S557A/S557A thymocytes were examined by Phos-tag immunoblot analysis (upper panel) and Western blot analysis (lower panel). (e) Analysis of
CD4 SP cell generation in thymocytes expressing phosphorylation-defective SHP-1S557A. CD3eD5/D5 mice that were transferred with mixed BM cells from
CD45.1þ WT and CD45.2þ SHP-1S557A/S557A mice were analysed for CD4 and CD8 expression on thymocytes by ﬂow cytometry 4 weeks after BMT.
Data are presented as mean±s.d. of triplicate assays (a,b) and representative of three (a,b), two (d) or ﬁve (e) independent experiments. Unpaired
two-tailed Student’s t test is used to calculate P values.
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Universite´ UM2, Marseille, France). Truncated PKD2 (a.a. 1-381) Tg mice were
established under Lck proximal promoter57. Tg mice expressing ThPOK
were established under Cd4 enhancer and promoter58. For the generation of
SHP-1S557A/S557A mice, C57BL/6-derived ES cells were co-transfected with a
circular form of targeting vector and two Cas9D10A and sgRNA expression vectors
(pX335, Addgene) to produce nicks in homology arms and genomic DNA for
efﬁcient homologous recombination (gRNAs for CRISPR were GTGGTGGA
GTGGGAGAAGCCC (pX335-SHP-short arm) and AGCTATGATATGGCTTC
ACA (pX335-SHP-long arm)). A ﬂoxed Neo cassette was deleted by crossing with
CAG-Cre Tg mice. Male and female mice of 7–12 weeks of age with C57BL/6
background were used for all experiments unless otherwise speciﬁed. For in vivo
negative selection model, C57BL/6 (H-2b) mice and B10.D2 (H-2d) mice were
obtained from Kyudo Co. Ltd. and Sankyo Labo Service Co. Inc., respectively. All
mice were maintained in ﬁlter-air, laminar-ﬂow enclosures and given standard
laboratory food and water ad libitum. Animal protocols were approved by the
committee of Ethics on Animal Experiment, Faculty of Medical Sciences,
Kyushu University.
Cells and reagents. DP thymocyte cell line, DPK cells59 were obtained from
J. G. Kaye (The Scripps Research Institute, La Jolla, CA, USA) and maintained in
RPMI1640 medium (SIGMA) supplemented with 10% fetal bovine serum (FBS)
(SIGMA), 100Uml 1 penicillin, 10mgml 1 streptomycin, 50mM 2-mercaptoehthanol,
0.1mM non-essential amino acids and 1mM sodium pyruvate. Murine ﬁbroblast
cell line DCEK transfected with I–Ek was kindly provided by K. Yasutomo
(Tokushima University, Tokushima, Japan) and maintained in DMEM medium
(SIGMA) supplemented with 10% FBS, 100Uml 1 penicillin, 10mgml 1
streptomycin and 50mM 2-mercaptoehthanol. To use DCEK cells as APC in
in vitro DPK differentiation assay, cells were treated with 50 mgml 1 mitomycin C
for 30min, washed with DMEM medium three times and plated on 96-well plates
at 1 105 cells per well. After 24 h, PCC88–104 peptides were added, and 2 h later,
5 104 DPK cells were plated. The mixed culture was incubated for 3 days
and analysed by ﬂow cytometry for the expression of CD4, CD8 and CD5.
Anti-PKD1/2/3 (pan) and anti-phospho-PKD1/2/3 (pan) were raised by
immunization of rabbits with peptides, CIIGEKSFRRSVVGTP and
CIIGEKpSFRRpSVVGTP, respectively, which are common sequence of PKD1,
PKD2 and PKD3. Speciﬁcity of these Abs was validated by Western blotting of
lysates from HEK293 cells that were transfected with PKD1, PKD2 and PKD3 or
WT PKD2, PKD2S707A, PKD2S711A and PKD2S707/711A (Fig. 1a). Anti-PKDs Ab
and anti-pPKDs Ab were used at 10 and 2 mgml 1, respectively. Anti-pSHP-1
(Ser557) was raised with a peptide, CASRTSpSKHKEE and used at 2 mgml 1.
Anti-CD3e (cat#553058, 145-2C11, 10 mgml 1), anti-CD4 (cat#553051, RM4-5,
1:100), anti-CD8 (cat#553033, 53-6.7, 1:100), anti-CD69 (cat#553236, H1.2F3,
1:100), anti-Va2 (cat#553288, B20.1, 1:80), anti-mouse TCR Vb screening panel
(cat#557004, 1:2) and anti-pCD247 (Y142) (pCD3z) (cat#558486, 1:50) were
purchased from BD Biosciences. Anti-CD5 (cat#100606, 53-7.3, 1:50), anti-TCRb
(cat#109206, H57, 1:20) and anti-CD4 (cat#100540, RM4-5, 1:100) were
from BioLegend. Anti-H–Y TCR (cat#11-9930-82, T3.70, 1:100), anti-TCRb
(cat#16-5961, H57) and anti-CD2 (cat#16-0021, RM2-5) were purchased from
eBioscience. Annexin V-FITC kit (cat#4700, 1:20) was from MBL. For intracellular
staining, anti-pErk1/2 (anti-ACTIVE MAPK) (cat#V8031, 1:40) was obtained from
Promega and anti-pZAP70 (cat#2717, 1:50), anti-pp38 (cat#4511, 1:50) and
anti-pJNK (cat#9255, 1:25) were from Cell Signaling Technology. For Western
blotting, anti-pErk1/2 (cat#4379, 1:2,000), anti-Erk1/2 (cat#9102, 1:1,000),
anti-NCK1 (cat#2319, 1:000) and anti-b-actin (cat#4970, 1:1,000) were obtained
from Cell Signaling Technology. Anti-SHP-1 (cat#sc-287, 1:200) was from Santa
Cruz Biotechnology. Anti-Gads (cat#06-983, 2.5 mgml 1) was from Upstate
Biotechnology. Goat anti-hamster IgG (cat#55397) was from MP Biomedicals.
OT-I TCR-speciﬁc OVA257–264 peptide (SIINFEKL) and OT-II TCR-speciﬁc
OVA323–339 peptide (ISQAVHAAHAEINEAGR) were from ABGENT. OVA323–339
variants, F9 and R9, were from ABGENT and MBL, respectively. OVA257–264
peptide variants, T4 (SIITFEKL) and G4 (SIIGFEKL), were purchased from
AnaSpec.
Immunoblotting. Preselection DP thymocytes were obtained from TAP-deﬁcient
mice transferred with OT-I Tg BM cells. For peptide stimulation, preselection DP
thymocytes were added with 10 mM OVA peptides followed by centrifugation at
4 C for packing, and stimulated at 37 C. For CD3 cross-linking, cells were stained
with 10mgml 1 anti-CD3 Ab at 4 C for 30min, washed twice with cold medium,
and then cross-linked by 100 mgml 1 goat anti-hamster IgG at 37 C. After
stimulation, cells were rapidly transferred on ice and added with cold HEPES
buffered saline for washing. Then, cells were lysed in lysis buffer containing 1%
Nonidet P-40, 1mM PMSF, protease inhibitor cocktail, 10mM NaF and 1mM
Na3VO4 and the lysates were mixed with sample buffer and applied to western blot
analysis60. For Phos-tag immunoblotting, 50Uml 1 benzonase (Novagen) was
also added in RIPA buffer. Images have been cropped for presentation. Full size
images are presented in Supplementary Figs 8–12.
Quantitative RT-PCR. For RT-PCR, following primers were used: PKD1
(F: 50-ATAACACTCTTCCAAAATGACACAGG-30 , R: 50-TCTCCCACATAATA
CACTACATTCGC-30), PKD2 (F: 50-GATGAGTTGGAGGATTCTGGTGTC-30,
R: 50-AGGGTGGTGCTGGATTTCCG-30), PKD3 (F: 50-AAGAGACATTATTG
GAGACTTGACAG-30 , R: 50-AGTGTGGGTTACTGCCTTGTG-30), Bcl-2
(F: 50-TCCTTCCAGCCTGAGAGCAAC-30 , R: 50-CACGACGGTAGCGACG
AGA-30), ThPOK (F: 50-GGAGCAGAGCCCCAAGCC-30, R: 50-GATTCCAATCA
GGTCATCCTCGG-30), Runx3 (F: 50-AGCACCACGAGCCACTTCAG-30 ,
R: 50-TAGGGAAGGAGCGGTCAAACTG-30), Runx3d (F: 50-AGCACGTCCACC
ATCGAG-30 , R: 50-TGCGACATGGCTTCCAACAG-30), Nur77 (F: 50-CCACCTC
TCCGAACCGTGACA-30, R: 50-GAGAAGATTGGTAGGGGAGGC-30).
Molecular indexing assay. RNA extracted from DP thymocytes of WT mice was
reverse-transcribed with oligo(dT) primers containing molecular indexing labels.
ds cDNA was ampliﬁed with gene-speciﬁc primers and ﬂuorescent dye-labelled
universal primers. The number of labels in ampliﬁed ds cDNA was detected by
microarray hybridization with Pixel System (Cellular Research).
Cell survival assay. Thymocytes were cultured in medium at 37 C with 5% CO2.
After incubation for different times, cells were stained with APC-conjugated
anti-CD4, PE-conjugated anti-CD8, FITC-conjugated Annexin V at the
concentration described in the ‘Cells and reagents’ section and propidium iodide at
room temperature for 15min, and immediately analysed by ﬂow cytometry.
In vivo negative selection model. C57BL/6 (H-2b) mice were backcrossed onto
B10.D2 (H-2d) mice and analysed for the expression of Vb5, Vb6 and Vb11.
Thymocytes expressing Vb5 or Vb11 are deleted by binding of Mtv-8 and Mtv-9
superantigens only when I–E is also expressed. Thus, deletion occurs on H-2b/d but
not H-2b/b backgrounds. Thymocytes expressing Vb6 are not deleted by these
superantigens.
Two-step differentiation assay. In vitro differentiation of CD4þCD8int
thymocytes was performed using puriﬁed DP thymocyets26. Thymocytes in
RPMI1640 medium supplemented with 10% (v/v) charcoal- and dextran-treated
FBS were plated on 96-well plates at 5 105 cells per well and stimulated for 20 h
in wells coated with 5 mgml 1 anti-TCRb and 10mgml 1 anti-CD2. Cells were
washed and immediately analysed for CD4 and CD8 expressions by ﬂow cytometry
(stimulatory culture) or transferred to a new plate, washed extensively, and
cultured for another 20 h in same medium, followed by the analysis for the
expression of CD4 and CD8 by ﬂow cytometry (recovery culture).
Co-receptor downregulation assay (Dulling assay). Co-receptor downregulation
was examined using OT-II thymocytes or preselection OT-I thymocytes27. Overall,
1 105 thioglycollate-induced peritoneal cells were used as APC and pulsed with
peptides before the addition of thymocytes (1.5 105–5.0 105) for stimulation of
OT-II thymocytes. To stimulate preselection OT-I thymocytes, peptides were loaded
on MHC class I expressed on thymocytes themselves. The expression of CD4 and
CD8 was analysed by ﬂow cytometry after 16–20h.
BM chimera for quantiﬁcation of redirection. For the analysis of
CD8-redirection, BM cells from WT or PKD2/3DT mice were suspended
in phosphate-buffered saline (PBS) and 1 107 cells were injected into
8Gy-irradiated TAP / mice. Then, 6 weeks after BMT, mice were dissected
and thymocytes were analysed. For mixed BM transfer, CD3eD5/D5 mice were
transferred with 5 106 each of CD45.1þ WT and CD45.2þ SHP-1S557A/S557A
BM cells and analysed 4 weeks after BMT.
Ca2þ mobilization. Thymocytes were freshly isolated and loaded with 1.2 mM
Fluo-4 (Molecular Probes) in phenol red-free RPMI1640 containing 5% FBS for
30min at 30 C. After washing, cells were stained with anti-CD3, phycoerythrin-
conjugated anti-CD8 and PerCP-Cy5.5 -conjugated anti-CD4 at the concentration
described in the ‘Cells and reagents’ section for 30min on ice. Cells were washed,
suspended in PBS containing 5% FBS, prewarmed to 37 C before analysis and
were kept at 37 C during event collection on FACSCalibur (Becton-Dickinson).
For cell stimulation, various concentrations of goat anti-hamster IgG were added to
crosslink anti-CD3 Abs. Maximum Ca2þ inﬂux was obtained by the addition of
10 mM ionomycin (Calbiochem). Mean ﬂuorescence ratio was calculated by FlowJo
software (Tree Star).
Intracellular staining. For intracellular staining of phosphorylated proteins,
thymocytes were stained with anti-CD3, anti-CD4 and anti-CD8 at the
concentration described in the ‘Cells and reagents’ section for 30min on ice and
cross-linked by goat anti-hamster IgG as described above. Cells were washed, ﬁxed
and permeabilized using cytoﬁx/cytoperm solution (BD Biosciences) for pCD3z,
pErk, pp38 and pJNK staining or ﬁxation/permeabilization buffer (eBioscience)
for pZAP70 staining. Data were analysed by FACSCalibur ﬂow cytometer and
CellQuest software (BD Biosciences).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12756
12 NATURE COMMUNICATIONS | 7:12756 | DOI: 10.1038/ncomms12756 | www.nature.com/naturecommunications
2D-DIGE. Thymocytes were freshly isolated and cultured for 16 h to upregulate
TCR. Cells were then incubated with 10 mgml 1 anti-CD3 mAb for 30min on ice
and stimulated by cross-linking by 100 mgml 1 goat anti-hamster IgG Ab for
2min at 37 C. The unstimulated WT, stimulated WT and stimulated PKD2/3DT
cells were lysed and phosphoproteins were enriched using PhosphoProtein
Puriﬁcation Kit (Qiagen). The interfering non-protein materials were subsequently
removed by 2-D Clean Up Kit (GE Healthcare). Overall, 30 mg of the resultant
phosphoproteins were minimally labelled with 400 pmol Cy2, Cy3 or Cy5
ﬂuorescent dye (CyDye DIGE Fluors, GE Healthcare) for 30min on ice. After
quenching the labelling reaction with 10 nmol lysine, differentially labelled samples
were mixed and subjected to ﬁrst-dimension isoelectric focusing on immobilized
pH gradient strips (24 cm; pH4–7) using an Ettan IPGphor II system. The
second-dimensional SDS–PAGE was carried out on 10% acrylamide gel. The Cy2,
Cy3 and Cy5 signals were individually acquired with a Typhoon 9400 scanner
(GE Healthcare).
Phos-tag western blotting. Lysates from thymocytes were subjected to PAGE
clean up kit (Nacalai tesque) before phosphate-afﬁnity SDS–PAGE is performed
using 6–7.5% acrylamide gels containing 25 or 50 mM Phos-tag acrylamide (Wako
chemicals) and 50 or 100mM MnCl2. After electrophoresis, gels were washed in
Trans-Blot Turbo transfer buffer (Bio-Rad) added with 1mM EDTA for 15min
and then incubated in the buffer without EDTA for 15min. Proteins were
transferred to polyvinylidene diﬂuoride (PVDF) membranes using Trans-Blot
Turbo Transfer System (Bio-Rad) with the program for HIGH molecular weight
proteins (1.3A, 25V, 10min) and analysed by immunoblotting. For l protein
phosphatase (l PP) treatment, lysates were treated with l PP for 30min at 30 C
before puriﬁcation using PAGE clean up kit.
Preparation of GST fusion proteins. SHP-1, Gads and NCK1 cDNAs were cloned
into pGEX-6P-1 vector (GE Healthcare). For the mutant GST fusion proteins,
Ser557 and Ser591 of SHP-1, Ser186 of Gads and Ser85 of NCK1 were changed
to alanine by site-directed mutagenesis. The vectors were transformed into
E. coli BL21 and GST fusion proteins were puriﬁed using glutathione sepharose
(GE Healthcare).
In vitro kinase assay. For in vitro kinase assay using [g-32P]ATP, 2 mg
GST-SHP-1, GST-Gads and GST-NCK1 were incubated with 50 ng active PKD2 or
PKD3 (Carna Bioscience) and 100 mM [g-32P]ATP (5 mCi) in 20 ml kinase buffer
(5mM MgCl2 and 20mM Tris–HCl, pH7.5) for 30min at 30 C. The reaction was
stopped by addition of sample buffer followed by heating at 95 C for 5min. Half of
the sample was subjected to 5–20% gradient SDS–PAGE and CBB staining.
Phosphorylated proteins were visualized by autoradiography.
Identiﬁcation of proteins and peptides by LC–MS/MS analysis. The 2D-DIGE
gel was silver-stained (Thermo Scientiﬁc) and protein spots were excised and
digested with trypsin (Promega). The obtained peptides were analysed by a
capillary liquid chromatography system (Waters/Micromass) connected to a
Q-TOF Ultima mass spectrometer (Waters/Micromass). Raw data were acquired
and processed using MassLynx version 4.0. (Waters/Micromass) to generate a peak
list ﬁle for MS/MS ion search. The peak list ﬁles were searched against the NCBI
non-redundant protein database restricted Mus musculus using the MS/MS ion
search on Mascot search engine (Matrix Science). To identify in vitro phosphor-
ylation sites, GST fusion proteins phosphorylated by active PKD2 or PKD3 were
subjected to SDS–PAGE. The gel was stained with Coomassie Brilliant Blue and
protein bands were excised and digested with trypsin. The resultant peptides were
analysed by an ADVANCE UHPLC (Michrom Bioresources) connected to an
Orbitrap Velos Pro mass spectrometer (for GST-Gads and GST-NCK1) or by an
EASY-nLC1000 UHPLC (Thermo Fisher Scientiﬁc) connected to an Orbitrap
Fusion Tribrid mass spectrometer (for GST-SHP-1).
Identiﬁcation of phosphopeptides by LC–MS/MS analysis. The unstimulated
WT, stimulated WT and stimulated PKD2/3DT thymocytes were lysed in buffer
containing 50mM Tris–HCl, pH 8.0, 8 M urea, 1mM DTT and PhosSTOP
phosphatase inhibitor mixture (Roche). The lysates were sonicated and cleared by
centrifugation at 20,000g at 4 C for 15min. Proteins (each 50mg) were reduced
with 5mM DTT for 30min and alkylated with 27.5mM iodoacetamide for 30min
in the dark. The urea concentration was then reduced to 1M before addition of
0.5 mg trypsin. After 4 h at 37 C, the digestion was quenched by acidiﬁcation
with 0.5% TFA. The digests were desalted using InertSep RP-1 (GL Sciences),
concentrated and adjusted to binding conditions for TiO2-based phosphopeptide
enrichment (80% acetonitrile, 0.5% TFA and 300mgml 1 lactic acid).
Phosphopeptides were enriched using 50mg of Titansphere Phos-TiO column
(GL Sciences) in accordance with the manufacturer’s instructions. Peptides were
eluted with 200ml of 5% ammonia and then with 200ml of 5% pyrrolidine.
The collected eluates were acidiﬁed with TFA and desalted using GL-Tip SDB
(GL Sciences). LC–MS/MS analysis of enriched phosphopeptides was performed
on an EASY-nLC 1200 UHPLC (Thermo Fisher Scientiﬁc) connected to a
Q Exactive Plus mass spectrometer (Thermo Fisher Scientiﬁc). The peptides were
separated on an EASY-Spray column (15 cm 75mm, PepMap C18, 3mm) with a
linear gradient from 4 to 28% ACN in 0–100min followed by increase to 80% ACN
in 100–110min. The mass spectrometer was operated in a data-dependent
acquisition mode with a top 10 MS/MS method. Raw data were converted to the
mgf ﬁles using Proteome Discoverer version 2.0 (Thermo Fisher Scientiﬁc), which
were then searched against the SwissProt database restricted to M. musculus using
the MS/MS ion search on Mascot search engine. The false discovery rate was set to
be o0.01. To generate extracted ion chromatograms, the raw data were processed
using Xcalibur software (Thermo Fisher Scientiﬁc).
Data availability. The mass spectrometry proteomics have been deposited in the
jPOST repository (https://repository.jpostdb.org) under the accession codes
JPST000031, JPST000032 and JPST000033. All other data supporting the ﬁndings
of this study are available within the article and Supplementary Information, and
can also be obtained from the corresponding author upon request.
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